Market Research

Psychedelic Invest is your source for the latest business and investing news about the burgeoning psychedelics industry.

Alto Neurosciences, Inc. Begins Trading at $16 Per Share

Feb 2 • 3 min read

Alto Neuroscience, Inc. (NYSE: ANRO) recently announced the launch of its significantly expanded initial public offering (IPO), offering 8,040,000 shares of common stock at a price of $16.00 per share. This pricing was at the top end of its initial estimate, which ranged from $14 to $16 per share, aiming for an estimated gross revenue…

Numinus Wellness Inc. Raises $6 Million

Feb 2 • 2 min read

Numinus Wellness Inc. (OTCQX: NUMIF) has successfully orchestrated a financing strategy to secure $6 million by entering into a definitive agreement for a bought deal, co-led by Eight Capital and a consortium including Stifel GMP, announced on Thursday. This financial maneuver involves the consortium’s acquisition of 50 million units of Numinus, priced at $0.12 each….

5 Risks While Operating in the Psychedelics Industry in 2024

Jan 26 • 4 min read

This post is brought to you by R&A Psy-Ins, an insurance broker operating at the forefront of the psychedelics industry. Risk #1 General Liability Insurance is a linchpin for psychedelic businesses and the most essential coverage to protect from a variety of claims including personal injury, bodily harm, property damage, and other situations that may…

Review of the Psychedelic Industry in 2023: A Year of Toil, Torment, and Triumph

Jan 19 • 4 min read

2023— the year that everyone in the psychedelic industry prepared for takeoff. Well, theoretical (but probable) take off. And, just a few weeks before 2023 came to an end, MAPS announced that it had submitted its much anticipated New Drug Application (NDA) to the Federal Drug Administration (FDA). You’ll probably be sick of hearing about…

aNUma: Pioneering Psychological Wellbeing Technology for Serious Disease Care and Beyond

Jan 10 • 6 min read

“We live in a “fix-it” culture with an expectation there’s a solution to every problem. But death is not a problem to solve. As has been said, death is not the opposite of life. Rather, death is the opposite of birth, an intrinsic part of the cycle of life. As death has become medicalized, we’ve…

Pages: 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253